Long-term treatment with SMS 201-995 in resistant acromegaly: effectiveness of high doses and continuous subcutaneous infusion.

Mehltretter, G; Heinz, S; Schopohl, J; von Werder, K; Müller, O A

Mehltretter, G; Heinz, S; Schopohl, J; von Werder, K; Müller, O A.

Affiliation

Mehltretter G; Medizinische Klinik Innenstadt, Universität München.

Klin Wochenschr ; 69(2): 83-90, 1991 Jan 22.

Article in En | MEDLINE | ID: mdl-1902881

Subject(s)

Acromegaly/therapy; Octreotide/administration & dosage; Acromegaly/blood; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Growth Hormone/blood; Humans; Infusion Pumps; Injections, Subcutaneous; Insulin-Like Growth Factor I/metabolism; Long-Term Care; Male; Middle Aged; Radioimmunoassay

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Acromegaly / Octreotide Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Klin Wochenschr Year: 1991 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links